The post UnitedHealth Group (UNH) tests resistance, but will earnings beat fuel a breakout? appeared on BitcoinEthereumNews.com. UnitedHealth Group (UNH), the beleaguered healthcare giant managing insurance and services for millions of Americans, is approaching a moment of truth on the charts. The next several trading sessions could determine whether its impressive recovery from the August lows has staying power or if sellers will reassert control. The stock is marching back toward a trendline that signals caution—a key level where former support became unforgiving resistance. Here is the setup I’m seeing in terms of technical analysis. The downsloping yellow trendline stretching across the chart wasn’t always the enemy of bulls. In fact, it served as reliable support during the entire rally from early 2025, guiding price action higher through $455.84 and all the way to $475.27 by April. Traders who understood the strength of that support line made good money riding that trend. But then something changed. The breakdown came swiftly. Once price sliced below that support trendline, the technical playbook wrote itself: former support becomes new resistance. And that’s exactly what happened at $439.32. Price rallied back to retest the now-broken trendline, and sellers were waiting. That rejection wasn’t subtle. UNH plummeted from $439 all the way down to the low $240s, a devastating decline that wiped out months of gains. This is the power of failed support levels; they often become formidable resistance, partly because traders remember the pain. After bottoming in August, UNH has now mounted an impressive recovery rally. From $240 to the current $365-$382 range represents a substantial bounce, the kind that makes you wonder if the worst is behind us. But here’s the rub: that same trendline that rejected price at $439 is now descending right into the path of this recovery, converging around $382.96. We’re about to find out if buyers have the conviction to reclaim what was lost. The recent… The post UnitedHealth Group (UNH) tests resistance, but will earnings beat fuel a breakout? appeared on BitcoinEthereumNews.com. UnitedHealth Group (UNH), the beleaguered healthcare giant managing insurance and services for millions of Americans, is approaching a moment of truth on the charts. The next several trading sessions could determine whether its impressive recovery from the August lows has staying power or if sellers will reassert control. The stock is marching back toward a trendline that signals caution—a key level where former support became unforgiving resistance. Here is the setup I’m seeing in terms of technical analysis. The downsloping yellow trendline stretching across the chart wasn’t always the enemy of bulls. In fact, it served as reliable support during the entire rally from early 2025, guiding price action higher through $455.84 and all the way to $475.27 by April. Traders who understood the strength of that support line made good money riding that trend. But then something changed. The breakdown came swiftly. Once price sliced below that support trendline, the technical playbook wrote itself: former support becomes new resistance. And that’s exactly what happened at $439.32. Price rallied back to retest the now-broken trendline, and sellers were waiting. That rejection wasn’t subtle. UNH plummeted from $439 all the way down to the low $240s, a devastating decline that wiped out months of gains. This is the power of failed support levels; they often become formidable resistance, partly because traders remember the pain. After bottoming in August, UNH has now mounted an impressive recovery rally. From $240 to the current $365-$382 range represents a substantial bounce, the kind that makes you wonder if the worst is behind us. But here’s the rub: that same trendline that rejected price at $439 is now descending right into the path of this recovery, converging around $382.96. We’re about to find out if buyers have the conviction to reclaim what was lost. The recent…

UnitedHealth Group (UNH) tests resistance, but will earnings beat fuel a breakout?

2025/10/29 01:42

UnitedHealth Group (UNH), the beleaguered healthcare giant managing insurance and services for millions of Americans, is approaching a moment of truth on the charts. The next several trading sessions could determine whether its impressive recovery from the August lows has staying power or if sellers will reassert control. The stock is marching back toward a trendline that signals caution—a key level where former support became unforgiving resistance.

Here is the setup I’m seeing in terms of technical analysis. The downsloping yellow trendline stretching across the chart wasn’t always the enemy of bulls. In fact, it served as reliable support during the entire rally from early 2025, guiding price action higher through $455.84 and all the way to $475.27 by April. Traders who understood the strength of that support line made good money riding that trend. But then something changed.

The breakdown came swiftly. Once price sliced below that support trendline, the technical playbook wrote itself: former support becomes new resistance. And that’s exactly what happened at $439.32. Price rallied back to retest the now-broken trendline, and sellers were waiting.

That rejection wasn’t subtle. UNH plummeted from $439 all the way down to the low $240s, a devastating decline that wiped out months of gains. This is the power of failed support levels; they often become formidable resistance, partly because traders remember the pain.

After bottoming in August, UNH has now mounted an impressive recovery rally. From $240 to the current $365-$382 range represents a substantial bounce, the kind that makes you wonder if the worst is behind us. But here’s the rub: that same trendline that rejected price at $439 is now descending right into the path of this recovery, converging around $382.96. We’re about to find out if buyers have the conviction to reclaim what was lost.

The recent earnings report adds context to this technical battle. UNH delivered $2.92 per share on $113.16 billion in revenue for Q3 2025, narrowly missing the Earnings Whisper number of $2.93 by just 0.34%. While the company beat consensus estimates and posted over 12% year-over-year revenue growth, that marginal miss against whisper expectations hasn’t ignited the kind of buying enthusiasm that breaks through major resistance. The fundamentals remain solid, but the market is clearly waiting for technical confirmation before committing capital aggressively.

What I’m watching now is how price behaves as it approaches this $382.96 convergence zone. The consolidation between $365.96 and $382.00 suggests traders are positioning themselves, but nobody wants to be the first one through the door. And rightfully so—memory of that $439 rejection is still fresh.

For the bulls to take control, there’s only one path: price must reclaim this trendline by breaking cleanly above $382.96 and holding above it. Not just a quick spike that fades, but a decisive close above with follow-through in subsequent sessions. If that happens, it would signal that the downtrend structure is breaking down and could open the door back toward $400 and potentially those former support levels around $439. A reclaimed trendline often becomes support again, which would completely change the technical landscape.

But let’s not ignore the bearish scenario, because it’s equally valid. The “Short Level” I’ve marked at $382.96 points to exactly what technical traders are watching. This is prime territory for resistance to hold once again. If price approaches this trendline and starts showing hesitation—spinning tops, long upper wicks, diminishing volume—it could signal another rejection is brewing. A failure here could send price back toward $365 support or lower, reinforcing the notion that this downtrend isn’t finished yet.

The risk management on both sides is straightforward. Bulls should wait for confirmation above $382.96 before entering, with stops below $375 to protect against a false breakout. Bears watching for shorts at resistance need tight stops above $385, because if this trendline gets reclaimed, the squeeze higher could be swift.

UNH stands at a technical crossroads where pattern memory is meeting recovery momentum. The earnings beat demonstrates business resilience, but the market’s tepid response keeps us anchored to the technicals. That $382.96 level is a crucial price point. It’s the line separating a continuation of the downtrend from the beginning of a potential reversal. The next few trading sessions should tell us which side wins this standoff.

Source: https://www.fxstreet.com/news/unitedhealth-group-unh-tests-resistance-but-will-earnings-beat-fuel-a-breakout-202510281357

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

Pavel's humanity, and Ton's challenges

Pavel's humanity, and Ton's challenges

I really like what Pavel mentioned about not using a mobile phone. Essentially, this is an "information fasting" approach to the challenges of information overload, contrasting with the "food fasting" that everyone loves using apps. One is metaphysical, the other is physical, but ultimately, both affect the mind and body, influencing hormones like cortisol. Now and in the future, attention is the scarcest resource. Being able to freely disconnect from electronic devices is a luxury, a freedom with its own barriers. Pavel is also an extreme craftsman. The advantage of being a craftsman is that you can lead a small team to create a killer app. However, the limitation is that Telegram, as the largest instant messaging software outside of China and the US, cannot become another Tencent platform. This same culture has also influenced its Web3 project, TON. By the way, let me talk about my close observation of TON over the past four years as the first Chinese institutional investor in the world. 1. The wrong technological path was taken. TON's stubborn insistence on using C++ seems like a kind of technological purist obsession. Historically, Russians have repeatedly taken the wrong turn on the "data technology tree": the Soviet Union failed to adapt to the transistor revolution, became obsessed with vacuum tube performance optimization, and missed the entire chip wave. They often overemphasize performance and control, but neglect the ecosystem and development experience. TON's SDK, toolchain, and documentation ecosystem lack standardization, making the development threshold too high; this is not a syntax problem, but a problem of lacking platform thinking. 2. Uneven ecological composition. Currently, it's basically only Russians and Chinese who are active, but resource allocation is clearly biased towards the Russian-speaking region. This is something everyone is already familiar with. 3. Oligopoly. Funding, traffic, and narrative resources within the ecosystem are concentrated on a few "top" companies/projects. Everyone knows they must curry favor with the "top" teams, but mid-tier projects are severely squeezed out. There is also a long-term power struggle between foundations and the oligopolistic "top" companies, resulting in constant internal friction. 4. Failure to accept oneself. Accepting and reconciling with oneself is crucial for any individual or organization. Only on this basis can you face yourself honestly and leverage your strengths while mitigating your weaknesses. However, TON seems obsessed with pitching to Musk, persuading American investors, and getting to the White House. The truth is, no matter how hard it tries, in the eyes of others, TON remains a public chain with a Russian background. In contrast, BNB didn't try to play the "American" role. Instead, it first became the most popular chain in the Eastern Time Zone, simultaneously creating a sense of FOMO (Fear of Missing Out) among Westerners, before smoothly expanding internationally—a much more effective approach. 5. The story of "adoption for 1 billion users" has been told for four years, and it's still just a story. Pavel keeps telling a grand story of "connecting Telegram's 1 billion users with the blockchain world," but this story has yet to truly materialize. The reason isn't that the vision is false, but rather structural constraints: In order to survive and ensure Pavel's personal safety (in recent years, Pavel has become increasingly obsessed with his physical safety, given several incidents, including the recent events in France), Telegram must maintain a "superficial" separation from TON to avoid crossing regulatory red lines; this separation prevents TON from ever truly integrating with Telegram's ecosystem. Even stablecoins like USDE have maintained a supply of only a few hundred million—indicating that the story is grand, but the reality is small. TON possesses the perfectionism of engineering geeks, yet lacks the warmth of ecological collaboration; it has a massive entry point, but is hampered by regulatory realities; it has its own advantages, but has not yet reconciled with itself. It has a narrative and ideals, but these need to be transformed into a sustainable balance of systems and incentives. I wish the TON ecosystem will continue to improve.
Share
PANews2025/10/30 14:00